This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed to pharmaceutical compositions including and methods using such compounds.

 
Web www.patentalert.com

< Core modified porphyrins

< Discrete absorbent article

> Carboline derivatives as PDE5 inhibitors

> Cancer treatments and pharmaceutical compositions therefor
~ 00231